These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 32198795)
1. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells. Fujii Y; Murata-Kamiya N; Hatakeyama M Cancer Sci; 2020 May; 111(5):1596-1606. PubMed ID: 32198795 [TBL] [Abstract][Full Text] [Related]
2. Dramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis. Nagase L; Hayashi T; Senda T; Hatakeyama M Sci Rep; 2015 Oct; 5():15749. PubMed ID: 26507409 [TBL] [Abstract][Full Text] [Related]
3. Ji X; Wu Q; Cao X; Liu S; Zhang J; Chen S; Shan J; Zhang Y; Li B; Zhao H Virulence; 2024 Dec; 15(1):2375549. PubMed ID: 38982595 [TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains. Lind J; Backert S; Hoffmann R; Eichler J; Yamaoka Y; Perez-Perez GI; Torres J; Sticht H; Tegtmeyer N BMC Microbiol; 2016 Sep; 16(1):201. PubMed ID: 27590005 [TBL] [Abstract][Full Text] [Related]
5. Differential Mechanisms for SHP2 Binding and Activation Are Exploited by Geographically Distinct Helicobacter pylori CagA Oncoproteins. Hayashi T; Senda M; Suzuki N; Nishikawa H; Ben C; Tang C; Nagase L; Inoue K; Senda T; Hatakeyama M Cell Rep; 2017 Sep; 20(12):2876-2890. PubMed ID: 28930683 [TBL] [Abstract][Full Text] [Related]
6. Malignant Helicobacter pylori-Associated Diseases: Gastric Cancer and MALT Lymphoma. Hatakeyama M Adv Exp Med Biol; 2019; 1149():135-149. PubMed ID: 31016622 [TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori CagA protein induces factors involved in the epithelial to mesenchymal transition (EMT) in infected gastric epithelial cells in an EPIYA- phosphorylation-dependent manner. Sougleri IS; Papadakos KS; Zadik MP; Mavri-Vavagianni M; Mentis AF; Sgouras DN FEBS J; 2016 Jan; 283(2):206-20. PubMed ID: 26907789 [TBL] [Abstract][Full Text] [Related]
8. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. Mueller D; Tegtmeyer N; Brandt S; Yamaoka Y; De Poire E; Sgouras D; Wessler S; Torres J; Smolka A; Backert S J Clin Invest; 2012 Apr; 122(4):1553-66. PubMed ID: 22378042 [TBL] [Abstract][Full Text] [Related]
9. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. Higashi H; Yokoyama K; Fujii Y; Ren S; Yuasa H; Saadat I; Murata-Kamiya N; Azuma T; Hatakeyama M J Biol Chem; 2005 Jun; 280(24):23130-7. PubMed ID: 15831497 [TBL] [Abstract][Full Text] [Related]
10. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. Ren S; Higashi H; Lu H; Azuma T; Hatakeyama M J Biol Chem; 2006 Oct; 281(43):32344-52. PubMed ID: 16954210 [TBL] [Abstract][Full Text] [Related]
11. Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus. Saju P; Murata-Kamiya N; Hayashi T; Senda Y; Nagase L; Noda S; Matsusaka K; Funata S; Kunita A; Urabe M; Seto Y; Fukayama M; Kaneda A; Hatakeyama M Nat Microbiol; 2016 Mar; 1():16026. PubMed ID: 27572445 [TBL] [Abstract][Full Text] [Related]
12. Natural variant of the Helicobacter pylori CagA oncoprotein that lost the ability to interact with PAR1. Hashi K; Murata-Kamiya N; Varon C; Mégraud F; Dominguez-Bello MG; Hatakeyama M Cancer Sci; 2014 Mar; 105(3):245-51. PubMed ID: 24354359 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate. Hashi K; Imai C; Yahara K; Tahmina K; Hayashi T; Azuma T; Miyabe-Nishiwaki T; Sato H; Matsuoka M; Niimi S; Okamoto M; Hatakeyama M Sci Rep; 2018 Oct; 8(1):15981. PubMed ID: 30374120 [TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of Western-type Helicobacter pylori strains. Lind J; Backert S; Pfleiderer K; Berg DE; Yamaoka Y; Sticht H; Tegtmeyer N PLoS One; 2014; 9(5):e96488. PubMed ID: 24800748 [TBL] [Abstract][Full Text] [Related]
16. Exploring the Distinct Binding and Activation Mechanisms for Different CagA Oncoproteins and SHP2 by Molecular Dynamics Simulations. Wang Q; Zhao WC; Fu XQ; Zheng QC Molecules; 2021 Feb; 26(4):. PubMed ID: 33562680 [TBL] [Abstract][Full Text] [Related]
17. Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein. Nishikawa H; Hatakeyama M Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28406453 [TBL] [Abstract][Full Text] [Related]
19. Structural Insights into the Binding Propensity of Human SHIP2 SH2 to Oncogenic CagA Isoforms from Wang Z; Shan Y; Wang R; Zhou H; Hu R; Li Y; Zhu J; Yang Y; Liu M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232599 [TBL] [Abstract][Full Text] [Related]
20. The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma. Ferreira RM; Machado JC; Leite M; Carneiro F; Figueiredo C Histopathology; 2012 May; 60(6):992-8. PubMed ID: 22348604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]